Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-062836
Filing Date
2025-05-02
Accepted
2025-05-02 16:30:20
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-20250331.htm   iXBRL 10-Q 1786076
2 EX-31.1 etnb-ex31_1.htm EX-31.1 16200
3 EX-31.2 etnb-ex31_2.htm EX-31.2 16212
4 EX-32 etnb-ex32.htm EX-32 17109
  Complete submission text file 0000950170-25-062836.txt   8134586

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT etnb-20250331.xsd EX-101.SCH 1290278
63 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20250331_htm.xml XML 1425335
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 25909101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)